COMMUNIQUÉS West-GlobeNewswire

Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares
05/05/2026
Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares Cash runway remains into Q4 2027, supporting continued funding of clinical programs and pre- [...]
Organ transplantation: ALS achieved CE Certification for PERLA®, The new class of solution – PPS – and launches a randomized comparative clinical trial (RCT)
05/05/2026
Press Release Organ transplantation: ALS achieved CE Certification for PERLA®, The new class of solution – PPS – and launches a randomized comparative clinical trial (RCT) ALS has received CE marking approval for PERLA [...]
Novonesis delivered strong start to the year with 7% organic sales growth in Q1
05/05/2026
COPENHAGEN, Denmark – May 5, 2026. In the first quarter of 2026, Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA margin of 37.8%. Ester Baiget, President & CEO: “The year started strong [...]
Interim report Q1 2026
05/05/2026
Strong start to the year with 7% organic sales growth and 37.8% adjusted EBITDA margin Ester Baiget, President & CEO: ” The year started strong with 7% organic sales growth against a high comparable. We delivered [...]
Santhera Publishes Agenda for its Annual General Meeting
05/05/2026
Ad hoc announcement pursuant to Art. 53 LR. Pratteln, Switzerland, May 5, 2026 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on May 26, [...]
Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer
05/05/2026
Series A financing led by 4BIO Capital, with major new investors Servier Ventures, Sound Bioventures, British Business Bank and Criteria Bio Ventures, supported by existing investors Abingworth and LifeArc Ventures [...]
neurocare group AG announces MDMA approval of TMS Devices in Saudi Arabia
05/05/2026
Munich, Germany and Riyadh, Saudi Arabia - neurocare group AG (“neurocare” or the “Company”), a best practice platform for mental health and performance, is pleased to announce the Saudi Food & Drug Authority (SFDA [...]
Axavive Under Investigation: Inspecting the Axon Renewal Anti-Aging Benefits of the Secret Golden Seed Astragaloside IV Skin Care Supplement
05/05/2026
Axavive Ingredients Bacopa Monnieri, Centella Asiatica, Cistanche Deserticola, and Collagen Support Pathways in the Axon Renewal Skin Support Supplement Framework Explained for 2026 Tallmadge, Ohio, May 04, 2026 (GLOBE [...]
GL Control Claims Evaluated: Investigating the Ingredients Benefits for Blood Sugar Trap Support
05/05/2026
GL Control Supplement Facts Reviewed: Cinnamon, Bitter Melon, Resveratrol, Licorice Root, Turmeric, and Coriander in the Blood Sugar Trap Liquid Tincture Formula for 2026 Tallmadge, OH, May 04, 2026 (GLOBE NEWSWIRE) -- [...]
Pennant Announces First Quarter 2026 Earnings Release and Call
05/05/2026
EAGLE, Idaho, May 04, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]
Axavive Claims Evaluated: The Golden Seed Switch for Healthy Skin Support
05/05/2026
Axavive Ingredients, Axon Renewal Framework, Astragaloside IV, Centella Asiatica, and Skin Support Supplement Claims Explained for 2026 Tallmadge, OH, May 04, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
Vital Wrist Monitor & Vital Wrist Ball Under Investigation: Evaluating the Brand Claims & Product Benefits
05/05/2026
How Vital Wrist Monitor's Blood Pressure Tracking and Vital Wrist Ball's Progressive Gyroscopic Resistance Work: At-Home Wrist Health Devices Explained for 2026 Miami, FL, May 04, 2026 (GLOBE NEWSWIRE) -- Results may [...]
Jushi Holdings Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
04/05/2026
BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSHF ) , a vertically integrated, multi-state cannabis operator, announced that it expects to [...]
Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
04/05/2026
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that Daniel Faga [...]
REGIONAL HEALTH PROPERTIES ANNOUNCES APPOINTMENT OF MARLIE DAVIS AS CHIEF FINANCIAL OFFICER
04/05/2026
ATLANTA, GA, May 04, 2026 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (OTCQB: RHEP) today announced the appointment of Marlie Davis as Chief Financial Officer and retirement of Mark Stockslager from his role as [...]
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
04/05/2026
DEER PARK, Ill., May 04, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]
Cellectis publiera ses résultats financiers du premier trimestre le 11 mai 2026
04/05/2026
NEW YORK, 04 mai 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa plateforme pionnière d’édition du génome pour développer des [...]
Teva to Present at the BofA Securities Health Care Conference
04/05/2026
PARSIPPANY, N.J., and TEL AVIV, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Eric Hughes, Teva's EVP of Global R&D & Chief Medical [...]
Cellectis to Report First Quarter Financial Results on May 11, 2026
04/05/2026
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell [...]

Pages